Back to Search Start Over

Unraveling Neuro-Proteogenomic Landscape and Therapeutic Implications for Human Behaviors and Psychiatric Disorders.

Authors :
Repetto L
Chen J
Yang Z
Zhai R
Timmers PRHJ
Li T
Twait EL
May-Wilson S
Muckian MD
Prins BP
Png G
Kooperberg C
Johansson Å
Hillary RF
Wheeler E
Pan L
He Y
Klasson S
Ahmad S
Peters JE
Gilly A
Karaleftheri M
Tsafantakis E
Haessler J
Gyllensten U
Harris SE
Wareham NJ
Göteson A
Lagging C
Ikram MA
van Duijn CM
Jern C
Landén M
Langenberg C
Deary IJ
Marioni RE
Enroth S
Reiner AP
Dedoussis G
Zeggini E
Butterworth AS
Mälarstig A
Wilson JF
Navarro P
Shen X
Source :
Research square [Res Sq] 2023 Mar 31. Date of Electronic Publication: 2023 Mar 31.
Publication Year :
2023

Abstract

Understanding the genetic basis of neuro-related proteins is essential for dissecting the molecular basis of human behavioral traits and the disease etiology of neuropsychiatric disorders. Here, the SCALLOP Consortium conducted a genome-wide association meta-analysis of over 12,500 individuals for 184 neuro-related proteins in human plasma. The analysis identified 117 cis-regulatory protein quantitative trait loci (cis-pQTL) and 166 trans-pQTL. The mapped pQTL capture on average 50% of each protein's heritability. Mendelian randomization analyses revealed multiple proteins showing potential causal effects on neuro-related traits such as sleeping, smoking, feelings, alcohol intake, mental health, and psychiatric disorders. Integrating with established drug information, we validated 13 out of 13 matched combinations of protein targets and diseases or side effects with available drugs, while suggesting hundreds of re-purposing and new therapeutic targets. This consortium effort provides a large-scale proteogenomic resource for biomedical research on human behaviors and other neuro-related phenotypes.<br />Competing Interests: Competing interests statement P.R.H.J.T is a salaried employee of BioAge Labs, Inc. The remaining authors declare no competing financial interests. R.E.M has received a speaker fee from Illumina, is an advisor to the Epigenetic Clock Development Foundation, and a scientific consultant for Optima Partners. E.W. is now an employee of AstraZeneca.

Details

Language :
English
ISSN :
2693-5015
Database :
MEDLINE
Journal :
Research square
Accession number :
37034613
Full Text :
https://doi.org/10.21203/rs.3.rs-2720355/v1